Factor v leiden mutation in reocclusion after intra-arterial thrombolysis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18927452.
- Also identified by DOI 10.1161/STROKEAHA.108.522771.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Reocclusion of intracranial arteries after successful recanalization is associated with poor clinical outcome. The role of Factor V Leiden mutation in intracranial arterial thrombosis/rethrombosis is unclear. We report the case of a patient who developed recurrent reocclusions of the middle cerebral artery after intra-arterial thrombolysis for acute ischemic stroke. The patient subsequently underwent transcatheter clot retrieval followed by successful stent-supported angioplasty of the occluded segment. He underwent a detailed workup for thrombophilia. The patient was detected to be heterozygous for Factor V Leiden mutation without any other cause for thrombophilia. Factor V Leiden mutation could be a contributing etiology for reocclusion after endovascular interventions in stroke. Systematic studies looking for thrombophilic mutations in patients with arterial reocclusion might be warranted.
Medical subject headings
- Factor V
- Fibrinolytic Agents
- Mutation
- Stroke
- Thrombolytic Therapy
- Tissue Plasminogen Activator